Latest Breaking News On - Validates biomarkers - Page 1 : comparemela.com

Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics is pleased to announce a milestone for its novel blood test for oesophageal adenocarcinoma, PromarkerEso, with the clinical validation of the biomarker panel in a second independent patient group.

United statesWestern australiaRichard lipscombeProteomics international laboratories ltdAustralasian proteomics societyProteomics internationalProteomics international laboratoriesValidates biomarkersOesophageal cancer bloodInternational laboratories ltdAnnual lorne proteomics symposiumVictorian cancer biobankManaging director dr richard lipscombeInternational laboratoriesHealth pharm generalproteomics international laboratories ltdAsx piq